Market Capitalization (Millions $) |
5,269 |
Shares
Outstanding (Millions) |
172 |
Employees |
86 |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-111 |
Cash Flow (TTM) (Millions $) |
121 |
Capital Exp. (TTM) (Millions $) |
2 |
Structure Therapeutics Inc
Structure Therapeutics Inc is a biotechnology company focused on discovering and developing small molecule drugs to target RNA structures implicated in various diseases. The company's research and development efforts are centered around the understanding of RNA structure and how it relates to disease pathways. By targeting specific RNA structures, Structure Therapeutics aims to develop innovative therapies that can effectively regulate gene expression and treat diseases such as cancer, genetic disorders, and viral infections. The company utilizes a combination of computational tools, high-throughput screening, and medicinal chemistry to identify and optimize small molecules that can modulate these RNA structures. Structure Therapeutics aims to provide novel therapeutic options that can address unmet medical needs and improve patient outcomes.
Company Address: 601 Gateway Blvd. South San Francisco 94080 CA
Company Phone Number: 457-1978 Stock Exchange / Ticker: NASDAQ GPCR
|